← FDA Drug Approvals (Drugs@FDA)

RIFAXIMIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NORWICH PHARMACEUTICALS INC · Approved 2024-06-20

Drug application

FDA Application #

ANDA214369

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIFAXIMIN

Generic name

Rifaximin

Active ingredients

RIFAXIMIN

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

NORWICH PHARMACEUTICALS INC

First approval

2024-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown